SpeeDx have added a new product to their portfolio — PlexMonkeypox.
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have added a new product to their portfolio; PlexMonkeypox* a single well, multiplex qPCR that simultaneously detects the Orthopoxvirus L1R gene as well as the Monkeypox virus specific Serine Protease Inhibitor (SPI) gene.
The World Health Organization’s (WHO) overall goal of surveillance, case investigation and contact tracing to stop the human-to-human transmission1 is key to controlling the current outbreak – Dr Lee Smith, Principal Scientist at SpeeDx and developer of PlexMonkeypox. “We don’t want to see another pandemic sweep the globe, fast and accurate surveillance is critical at this time.”
PlexMonkeypox provides laboratories with the tool to research Monkeypox outbreaks in their surrounding communities.
*Research Use Only, not for use in diagnostic procedures